Novel 12-LOX Inhibitor Fast Tracked for Heparin-Induced Thrombocytopenia
The Food and Drug Administration (FDA) has granted Fast Track designation to VLX-1005 for the treatment and prevention of heparin-induced thrombocytopenia and thrombosis. VLX-1005 is a first-in-class, selective small molecule inhibitor of 12-lipoxygenase, a key…